AU3684395A - Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases - Google Patents

Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases

Info

Publication number
AU3684395A
AU3684395A AU36843/95A AU3684395A AU3684395A AU 3684395 A AU3684395 A AU 3684395A AU 36843/95 A AU36843/95 A AU 36843/95A AU 3684395 A AU3684395 A AU 3684395A AU 3684395 A AU3684395 A AU 3684395A
Authority
AU
Australia
Prior art keywords
camptothecin
medicament
derivatives
manufacture
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36843/95A
Other languages
English (en)
Inventor
Leon T. Atlas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LEON T ATLAS
Original Assignee
LEON T ATLAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LEON T ATLAS filed Critical LEON T ATLAS
Publication of AU3684395A publication Critical patent/AU3684395A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU36843/95A 1994-10-06 1995-09-26 Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases Abandoned AU3684395A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31945194A 1994-10-06 1994-10-06
US319451 1994-10-06
PCT/US1995/012250 WO1996011005A2 (fr) 1994-10-06 1995-09-26 Utilisation de camptothecine ou de derives de camptothecine dans la fabrication d'un medicament destine au traitement de maladies virales

Publications (1)

Publication Number Publication Date
AU3684395A true AU3684395A (en) 1996-05-02

Family

ID=23242292

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36843/95A Abandoned AU3684395A (en) 1994-10-06 1995-09-26 Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases

Country Status (2)

Country Link
AU (1) AU3684395A (fr)
WO (1) WO1996011005A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395541B1 (en) * 1996-05-23 2002-05-28 The Rockefeller University Methods for the identification of compounds capable of inhibiting HIV-1 viral replication employing murine cell lines expressing human topoisomerase I
IL134592A0 (en) * 1998-06-18 2001-04-30 Univ George Washington Compositions comprising camptothecin compounds for the treatment of cancer with reduced side effects
FR2782009B1 (fr) * 1998-08-05 2000-09-15 Rhone Poulenc Rorer Sa Utilisation de derives de la comptothecine, avec une toxicite gastro-intestinale reduite
NZ509859A (en) 1998-08-05 2003-09-26 Aventis Pharma S Use of camptothecin derivatives, with reduced gastrointestinal toxicity
AU2001268653A1 (en) * 2000-06-28 2002-01-08 Supergen, Inc. Combination hiv therapy including camptothecin
US7074824B2 (en) 2001-07-31 2006-07-11 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
US6962944B2 (en) 2001-07-31 2005-11-08 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
EP1542682A4 (fr) * 2002-07-18 2007-10-31 Univ Utah Res Found Nouveaux inhibiteurs des ubiquitine isopeptidases
WO2014186423A1 (fr) * 2013-05-13 2014-11-20 Oyagen, Inc. Traitement combiné pour traiter le vih et le sida
EP3915549A1 (fr) * 2020-05-26 2021-12-01 Merck Patent GmbH Inducteurs de sénescence destinés à être utilisés dans le traitement et/ou la prévention de maladies induites par un virus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894456A (en) * 1987-03-31 1990-01-16 Research Triangle Institute Synthesis of camptothecin and analogs thereof
US5422344A (en) * 1990-05-08 1995-06-06 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Method of treating retroviral infections in mammals
US5162532A (en) * 1990-12-20 1992-11-10 North Carolina State University Intermediates and method of making camptothecin and camptothecin analogs
IT1269862B (it) * 1994-05-30 1997-04-15 Indena Spa Alcaloidi da mappia foetida, loro uso e formulazioni che li contengono

Also Published As

Publication number Publication date
WO1996011005A3 (fr) 1996-05-30
WO1996011005A2 (fr) 1996-04-18

Similar Documents

Publication Publication Date Title
EP1029540A3 (fr) Utilisation de la droloxifène pour le traitement de maladies cardiovasculaires
IL127714A0 (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic depressive bipolar disorders
AU7867994A (en) Hemofiltration of mediator-related diseases
IL174732A0 (en) Use of crystal modification of a n-phenyl-2-pyrimidineamine derivative in the preparation of a medicament for the treatment of restenosis
AU4048295A (en) Peptide medicaments for the treatment of disease
AU2845492A (en) Dipyridamole for the treatment of proliferative diseases
AU3560495A (en) Medicament inhaler
AU2549797A (en) Xanthone analogs for the treatment of infectious diseases
AU3009801A (en) Combinations of medicaments for treating viral diseases
AU8910891A (en) Treatment of lung diseases
ZA983602B (en) Use of tetrahydropyridine derivatives for the preparation of drugs for the treatment of diseases which cause demyelination
AU3501697A (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of postischemic neurodegeneration
AU6858996A (en) Pharmaceutical compositions for the treatment of infectious diseases
AU9173191A (en) Medicaments for the treatment of papillomavirus diseases
AU3684395A (en) Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
AU1116895A (en) Use of theophylline for the manufacture of a medicament for the treatment of asthma
AU2027495A (en) Pharmaceutical composition for treating hemorrhoidal diseases
AU2806692A (en) Medicament for the treatment of anxiety
AU2787495A (en) Use of copolymer-1 for the manufacture of a medicament for the treatment of optic neuritis
EP0740936A3 (fr) Utilisation des dérivés du benzopyrane pour l' obtention de compositions pharmaceutiques destinées au traitement des pathologies liées a l'énchangeur Cl-/HCO3-,Na+ indépendant
EP0765661A3 (fr) Utilisation de l'acide docosahexaénique pour la fabrication d'un médicament pour le traitement de la glomérulonephrite
AU2748895A (en) Medical nebuliser
AU4476089A (en) Use of azepinone derivatives for the treatment of respiratory tract disorders
AU3574793A (en) Remedy for airway diseases
AU7726796A (en) Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma